◆Glosfer Labs=The CEO structure changed from the previous co-CEOs Lee Dae-sik and Kim Tae-won to CEO Lee only, as CEO Kim resigned due to personal reasons.
◆Myeongseong TNS=Selected for a national project related to re-manufacturing technology development. The total R&D cost is KRW 4.322 billion.
◆Jeonjin Bio Pharm=Decided to issue KRW 3.5 billion worth of anonymous, interest-bearing, unsecured convertible bonds (CB) to KB Securities and others to raise operating funds.
◆Green Cross MS=Signed a supply contract for COVID-19 diagnostic kits worth KRW 20.886 billion with Asia Bridge Holdings. The contract amount corresponds to 22.20% of last year’s sales.
◆Lumimicro=Acquired 2,127,659 shares of its affiliate Vibozone in cash for approximately KRW 50 billion. The acquisition amount is about 45.87% of its equity capital.
◆Jaan=Decided to issue KRW 13 billion worth of anonymous, interest-bearing, unsecured, secured private convertible bonds (CB) to SC Lowy Financial (HK) Limited to raise facility and operating funds.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
